Abstract:The title compound (common name eplerenone), C24H30O6, is an aldosterone receptor antagonist. From the isopropyl acetate solution the compound crystallizes in monoclinic space group P 21 with a = 8.811(1) Å, b = 11.250(1) Å, c = 11.079(1) Å, β = 93.822(12)°, Z = 2. The molecule contains three six membered rings, two five membered rings and one three membered ring. Both five membered rings display envelope conformation, whereas three six membered rings show different conformation: chair, half-chair and envelope. In the crystal the eplerenone molecules link to one another via intermolecular weak C–H···O hydrogen bonding to form the smaller cavity of 12.0(1) Å3 between eplerenone molecules, no solvent molecule filled in this cavity.

3Β,12β,14α-Trihydroxypregnan-20-one

20-Oxopregna-5,16-dien-3β-yl Acetate

Crystal Structure of 9Α,11-Epoxy-7α-(methoxycarbonyl)-3-oxo-17α-pregn-4-ene-21,17-carbolactone

9α-Bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione

9 alpha-bromo-11 beta-hydroxypregna-1,4,16-triene-3,20-dione

(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

3Β-Acetoxy-17-ethylenedioxyandrost-5-ene

Methyl 3Β-Methoxy-carbon-yloxy-4,4-di-methyl-17-oxo-16α-(3-oxobut-yl)-16β-carboxylate.

Pregna-1,4,9(11),16-tetraene-3,20-dione

11&#946;,17a&#945;-Dihydroxy-17a&#946;-methyl-d-homoandrosta-1,4-diene-3,17-dione monohydrate

20-O-β-d-xylopyranos-yl(1→6)-β-d-glucopyranosyl-20(s)-protopanaxadiol Methanol Solvate.

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

11Β,17aα-Dihydroxy-17aβ-methyl-d-homoandrosta-1,4-diene-3,17-dione Monohydrate

4-(3,5-Dioxo-10-oxa-4-aza-tricyclo-[5.2.1.0]decan-4-yl)-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

4&#946;-Hydroxy-12,13-epoxytrichothec-9-ene

Methyl 3&#946;-methoxycarbonyloxy-4,4-dimethyl-17-oxo-16&#945;-(3-oxobutyl)-16&#946;-carboxylate

4Β-Hydroxy-12,13-epoxytrichothec-9-ene

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitrophenyl)‐4‐(4‐chlorophenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thiadiazoline

4-(3,5-Dioxo-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decan-4-yl)-10- oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

3Β,12β,14α-Trihydroxypregnan-20-one

20-Oxopregna-5,16-dien-3β-yl Acetate

Crystal Structure of 9Α,11-Epoxy-7α-(methoxycarbonyl)-3-oxo-17α-pregn-4-ene-21,17-carbolactone

9α-Bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione

9 alpha-bromo-11 beta-hydroxypregna-1,4,16-triene-3,20-dione

(1R,4s,8r,9r,12s,13s,14r,16s,17r,19r)-17-[(ethylsulfanyl)methyl]-9,14-dihydroxy-7,7-dimethyl-2,18-dioxo-3,10-dioxapentacyclo[14.2.1.01,13.04,12.08,12]nonadecan-19-yl Acetate Acetone Solvate

3Β-Acetoxy-17-ethylenedioxyandrost-5-ene

Methyl 3Β-Methoxy-carbon-yloxy-4,4-di-methyl-17-oxo-16α-(3-oxobut-yl)-16β-carboxylate.

Pregna-1,4,9(11),16-tetraene-3,20-dione

11&amp;#946;,17a&amp;#945;-Dihydroxy-17a&amp;#946;-methyl-d-homoandrosta-1,4-diene-3,17-dione monohydrate

20-O-β-d-xylopyranos-yl(1→6)-β-d-glucopyranosyl-20(s)-protopanaxadiol Methanol Solvate.

(±)-(3aRS,4SR)-9-Chloro-2-(2-chloro-4-nitrophenyl)-4-(4-chlorophenyl)-3a,4-diethoxy-6,8-dimethoxychromano[4,3-d]-Δ1,9b-1,2,3-thiadiazoline

(+/-)-(3ars,4sr)-9-Chloro-2-(2-Chloro-4-Nitrophenyl)4-(4-Chlorophenyl)-3 A,4-Diethoxy-6,8-Dimethoxy-Chromano[4,3-D]-Delta(1,9b)-1,2,3-Thiadiazoli Ne

11Β,17aα-Dihydroxy-17aβ-methyl-d-homoandrosta-1,4-diene-3,17-dione Monohydrate

4-(3,5-Dioxo-10-oxa-4-aza-tricyclo-[5.2.1.0]decan-4-yl)-10-oxa-4-aza-tricyclo-[5.2.1.0]decane-3,5-dione.

Ethyl (4a<i>R</i>*,7<i>S</i>*,8<i>S</i>*,8a<i>S</i>*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

4&amp;#946;-Hydroxy-12,13-epoxytrichothec-9-ene

Methyl 3&amp;#946;-methoxycarbonyloxy-4,4-dimethyl-17-oxo-16&amp;#945;-(3-oxobutyl)-16&amp;#946;-carboxylate

4Β-Hydroxy-12,13-epoxytrichothec-9-ene

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitro­phenyl)‐4‐(4‐chloro­phenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thia­diazo­line

4-(3,5-Dioxo-10-oxa-4-azatricyclo-[5.2.1.0 2,6]decan-4-yl)-10- oxa-4-azatricyclo-[5.2.1.0 2,6]decane-3,5-dione

11β,17aα-Dihydroxy-17aβ-methyl-d-homoandrosta-1,4-diene-3,17-dione monohydrate

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

4β-Hydroxy-12,13-epoxytrichothec-9-ene

Methyl 3β-methoxycarbonyloxy-4,4-dimethyl-17-oxo-16α-(3-oxobutyl)-16β-carboxylate

(±)‐(3Ars,4sr)‐9‐chloro‐3a,4‐diethoxy‐6,8‐dimethoxy‐2‐(2‐chloro‐4‐nitrophenyl)‐4‐(4‐chlorophenyl)chromano[4,3‐d]‐δ1,9b‐1,2,3‐thiadiazoline